Cholangiocarcinoma is the second most common primary tumor of the liver. The incidence
and mortality of its intrahepatic form has been increasing over the past 2 decades. Currently …

Objectives: To determine the prognostic implication of the number and station of LNM, and
the minimal number of LNs needed for evaluation to accurately stage patients with …

Background Laparoscopic liver resection (LLR) has gained increasing acceptance for
surgical treatment of malignant and benign liver tumors. LLR for intrahepatic …

Introduction Intrahepatic cholangiocarcinoma (ICC) remains an uncommon disease with a
rising incidence worldwide. We sought to identify trends in therapeutic approaches and …

Objective: This study aimed to evaluate the oncological adequacy of lymphadenectomy
(LND) for biliary tumors and surgical outcomes of resections performed using robotic …

Currently, the only curative treatment for cholangiocarcinoma (CCA) is surgical resection,
though this treatment is possible in less than 40% of patients. However, recent …

Background Lymphadenectomy ensures accurate staging for patients with intrahepatic
cholangiocarcinoma, especially for those without preoperatively suspected positive lymph …

Background The role of routine lymph node dissection (LND) in the surgical treatment of
intrahepatic cholangiocarcinoma (ICC) remains controversial. The objective of this study …

Background & Aims Lymph-nodal status is an important predictor of survival in intrahepatic
cholangiocarcinoma (iCCA), but the need to perform lymphadenectomy in patients with …

Background Tumor burden is an important factor in defining prognosis among patients with
primary and secondary liver cancers. Although the eighth edition of the American Joint …